BiotechTube

ABT-SLV176

Phase 3Withdrawn
0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hypogonadism

Conditions

Hypogonadism, Testosterone Deficiency

Trial Timeline

Mar 1, 2014 → Jun 1, 2015

NCT ID
NCT02082197

About ABT-SLV176

ABT-SLV176 is a phase 3 stage product being developed by AbbVie for Hypogonadism. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT02082197. Target conditions include Hypogonadism, Testosterone Deficiency.

What happened to similar drugs?

6 of 18 similar drugs in Hypogonadism were approved

Approved (6) Terminated (2) Active (12)
✅Topical Testosterone SolutionEli LillyApproved
✅AndroGel® + PlaceboAbbVieApproved
✅AndroGel 1.62%AbbVieApproved
✅Testosterone Undeconate (Nebido, BAY86-5037) + PlaceboBayerApproved
✅NEBIDO + PLACEBOBayerApproved
✅JatenzoICON plc.Approved
🔄Testosterone Solution + Placebo SolutionEli LillyPhase 3

Hype Score Breakdown

Clinical
17
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT02082197Phase 3Withdrawn

Competing Products

20 competing products in Hypogonadism

See all competitors
ProductCompanyStageHype Score
Topical Testosterone SolutionEli LillyApproved
43
Testosterone Solution + Placebo SolutionEli LillyPhase 3
40
Testosterone MD-LotionEli LillyPhase 2
35
Testosterone MD-LotionEli LillyPhase 3
40
Testosterone MD-LotionEli LillyPhase 3
40
Testosterone Gel 1.62% + Testosterone Gel 1.62%AbbViePhase 1
29
AndroGel® + PlaceboAbbVieApproved
43
AndroGel 1.62%AbbVieApproved
43
Recombinant human luteinizing hormone (r-hLH) + Recombinant human follicle-stimulating hormone (r-hFSH) + Human chorionic gonadotropin (hCG)MerckPhase 3
40
Oral testosterone undecanoate (Andriol) + PlaceboMerckPhase 2
35
Reference: Follitropin alfa + ZoladexMerckPhase 1
29
Testosterone + Alendronate + Placebo Alendronate + Placebo TestosteroneMerckPhase 2
27
Testosterone Enanthate + FinasterideMerckPhase 2
35
Testim 1% (testosterone gel) + PlaceboMerckPhase 2
27
Investigational new drug company code: BGS649 + PlaceboNovartisPhase 2
27
Test formulation + Reference formulationPfizerPhase 1
29
Testosterone ProductBayerPre-clinical
23
Testosterone undecanoate (TU) - NebidoTMBayerPhase 3
37
Testosterone Undeconate (Nebido-R, BAY86-5037)BayerPre-clinical
23
Testosterone Undeconate (Nebido, BAY86-5037) + PlaceboBayerApproved
32